Darien Parhad

Darien Parhad serves as the chief financial officer at Evozyne. He is responsible for financial accounting and reporting, budgeting, tax, treasury management and human resources. With over 20 years of experience, Darien was previously the controller for Marathon Pharmaceuticals and Lundbeck, as well as director of accounting at Ovation Pharmaceuticals. He began his career at Deloitte & Touche, working in roles of increasing responsibility. He is a certified public accountant and received a bachelor’s degree in accountancy from DePaul University.